Results 11 to 20 of about 145,684 (315)

Inflammatory Articular Disease in Patients with Inflammatory Bowel Disease: Result of the Swiss IBD Cohort Study [PDF]

, 2015
BACKGROUND Inflammatory bowel diseases (IBD) are systemic conditions that commonly display extraintestinal manifestations. Inflammatory articular disease (IAD: axial or peripheral) is the most common extraintestinal manifestation.
the Swiss IBD Cohort Study Group, Swiss IBD Cohort, Study Group, Juillerat, P., Finckh, A., Finckh, Axel, Pittet, V., Gabay, Cem, Fournier, N., Ditisheim, Saskia, Gabay, C., Fournier, Nicolas, Ditisheim, S., Michetti, P., Juillerat, Pascal, Michetti, Pierre, Ditisheim, Saskia Isabel, Pittet, Valerie   +16 more
core   +1 more source

EVALUATION OF INTRAYOLK SAC INOCULATION OF INFECTIOUS BURSAL DISEASE VACCINE ON IMMUNE RESPONSES IN NEWLY HATCHED BROILER CHICKS [PDF]

Basrah Journal of Veterinary Research, 2018
A total of 60 one-day old Ross broiler chicks were used in this study. The birds were divided into four groups. The first group A was vaccinated against IBD with a Cevac IBD L vaccine at one-day old by intra-yolk sac method (lYS) with a dose of 0.5ml ...
Harith A. Najem
doaj   +1 more source

Deadly IBD [PDF]

Inflammatory Bowel Diseases, 1997
Survival and Cause-Specific Mortality in Inflammatory Bowel Disease: A Population-Based Cohort Study. Persson PG, Bernell O, Leijonmarck CE, Farahmand BY, Hellers G, Ahlbom A. Gastroenterology 1996;110:1339-45.
openaire   +2 more sources

Association of IBD specific treatment and prevalence of pain in the Swiss IBD cohort study [PDF]

, 2019
BackgroundExtraintestinal manifestations (EIM) contribute significantly to the burden of disease in inflammatory bowel disease (IBD). Pain is a leading symptom in IBD and could be seen as an EIM itself. Treatment of IBD associated pain is challenging and
Thomas Greuter, Philipp Schreiner, Vavricka, Stephan, Nicolas Fournier, Greuter, T., Gerhard Rogler (139954), Greuter, Thomas, Lorenz Bon (6635534), Zeitz, J., Bon, L., Frei, Pascal, Misselwitz, B., Luc Biedermann (139959), Scharl, S., Biedermann, L., Stephan Vavricka (2987307), Michael Scharl (139957), Valerie Pittet, Fournier, N., Frei, P., Fournier, Nicolas, Gerhard Rogler, Nicolas Fournier (2842580), Pascal Frei, Scharl, Michael, Zeitz, Jonas, Schreiner, Philipp, Valerie Pittet (3164283), Rogler, Gerhard, Bon, Lorenz, Schreiner, P., Rogler, G., Sylvie Scharl (2805235), Benjamin Misselwitz (149517), Luc Biedermann, Benjamin Misselwitz, Scharl, M., Jonas Zeitz (389786), Swiss IBD Cohort Study Group, Biedermann, Luc, Misselwitz, Benjamin, Stephan Vavricka, Pittet, V., Pascal Frei (139961), Jonas Zeitz, Vavricka, S., Sylvie Scharl, Thomas Greuter (6527111), Scharl, Sylvie, Michael Scharl, Lorenz Bon, Philipp Schreiner (6527108), Pittet, Valerie; https://orcid.org/   +52 more
core   +1 more source

Common and Rare Variant Prediction and Penetrance of IBD in a Large, Multi-ethnic, Health System-based Biobank Cohort [PDF]

, 2021
BACKGROUND AND AIMS: Polygenic risk scores (PRS) may soon be used to predict inflammatory bowel disease (IBD) risk in prevention efforts. We leveraged exome-sequence and single nucleotide polymorphism (SNP) array data from 29,358 individuals in the ...
Natl Inst Diabet Digestive Kidney, Moscati, Arden, UK IBD Genetics Consortium, Gettler, Kyle, Daly, Mark J., Cho, Judy H., Levantovsky, Rachel   +6 more
core   +1 more source

Quercetin effectively improves LPS-induced intestinal inflammation, pyroptosis, and disruption of the barrier function through the TLR4/NF-κB/NLRP3 signaling pathway in vivo and in vitro

Food & Nutrition Research, 2022
Background: Inflammatory bowel diseases are characterized by the alterations of the mucosa and gastrointestinal physiology, and the core of these alterations is endothelial cells.
Hui-Xin Zhang, Ye-Ye Li, Zhong-Jie Liu, Jiu-Feng Wang   +3 more
doaj   +1 more source

Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study [PDF]

, 2017
BACKGROUND Extraintestinal manifestations (EIMs) in patients with inflammatory bowel disease (IBD) are frequently observed. Little is known about the efficacy of anti-tumor necrosis factor (TNF) in EIM management.
Safroneeva, Ekaterina, Alex Straumann, Safroneeva, E., Thomas Greuter, Nicolas Fournier, Greuter, T., Gantenbein, C., Greuter, Thomas, Zeitz, J., Marijana Protic, Christine N. Manser, Martin Gubler, Heinrich, H., Juillerat, Pascal, Misselwitz, B., Spoerri, M., Raja Ali, R.A., Biedermann, L., Alain M. Schoepfer, Spoerri, Muriel, Froehlich, Florian, Fournier, N., Ekaterina Safroneeva, Fournier, Nicolas, Gerhard Rogler, Seibold, Frank, Froehlich, F., Scharl, Michael, Zeitz, Jonas, Michetti, P., Manser, C.N., Gantenbein, Claudine, Straumann, A., Pierre Michetti, Vavricka, Stephan R, Protic, M., Seibold, F., Rogler, Gerhard, Juillerat, P., Rogler, G., Manser, Christine N, Luc Biedermann, Benjamin Misselwitz, Vavricka, S.R., Frank Seibold, Scharl, M., Gubler, Martin, Michetti, Pierre, Stephan R. Vavricka, Gubler, M., Swiss IBD Cohort Study Group, Biedermann, Luc, Schoepfer, Alain M, Claudine Gantenbein, Misselwitz, Benjamin, Heinrich, Henriette, Straumann, Alex, Pascal Juillerat, Protic, Marijana, Jonas Zeitz, Florian Froehlich, Raja Affendi Raja Ali, Schoepfer, A.M., Henriette Heinrich, Raja Ali, Raja Affendi, Muriel Spoerri, Michael Scharl, Study Group, Swiss IBD Cohort   +67 more
core   +1 more source

In dogs with chronic enteropathy (idiopathic inflammatory bowel disease) is budesonide more effective than prednisolone or prednisone in resolving clinical signs?

Veterinary Evidence, 2023
PICO Question In dogs with chronic enteropathy (idiopathic inflammatory bowel disease) is budesonide more effective than prednisolone or prednisone in resolving clinical signs or improving the canine inflammatory bowel disease (IBD) activity index ...
Victoria Alice Coates
doaj   +1 more source

Effect of closed and permanent stoma on disease course, psychological well-being and working capacity in Swiss IBD cohort study patients [PDF]

, 2022
BACKGROUND: Little is known about the impact of ostomy formation in inflammatory bowel disease patients on course of disease, psychological well-being, quality of life and working capacity. METHODS: We analyzed patients over a follow-up of up to 16 years
Dora, Babara, Bianchi, R., Rogler, Gerhard, Mamadou-Pathé, B., Mamadou-Pathé, Barry, von Känel, R., Greuter, T., Schreiner, P., Rickenbacher, Andreas, Greuter, Thomas, Rogler, G., Kloth, P., Kloth, Patrizia, Roth, René; https://orcid.org/, Rickenbacher, A., Burk, Sabine, Roth, René, Scharl, M., Roth, R., von Känel, Roland, Bianchi, Rahel; https://orcid.org/, Rossel, J.B., Misselwitz, B., Burk, S., Biedermann, Luc, Misselwitz, Benjamin, Biedermann, L., Rossel, Jean-Benoit; https://orcid.org/, von Känel, Roland; https://orcid.org/, Turina, Matthias, Dora, B., Scharl, Michael, Bianchi, Rahel, Turina, M., Schreiner, Philipp, Rossel, Jean-Benoit   +35 more
core   +1 more source

The Information Needs and Preferences of Persons with Longstanding Inflammatory Bowel Disease

Canadian Journal of Gastroenterology, 2012
BACKGROUND: Understanding the information needs and preferred vehicles of information delivery to patients with inflammatory bowel disease (IBD) will enhance their care.
Samantha Wong, John R Walker, Rachel Carr, Lesley A Graff, Ian Clara, Stephen Promislow, Linda Rogala, Norine Miller, Patricia Rawsthorne, Charles N Bernstein   +9 more
doaj   +1 more source